Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Theragen Etex Statistics

Total Valuation

Theragen Etex has a market cap or net worth of KRW 106.38 billion. The enterprise value is 139.22 billion.

Market Cap	106.38B
Enterprise Value	139.22B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Theragen Etex has 36.68 million shares outstanding. The number of shares has increased by 0.73% in one year.

Current Share Class	36.68M
Shares Outstanding	36.68M
Shares Change (YoY)	+0.73%
Shares Change (QoQ)	+2.92%
Owned by Insiders (%)	27.43%
Owned by Institutions (%)	0.90%
Float	24.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.40
PB Ratio	0.75
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	32.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.45, with an EV/FCF ratio of -25.73.

EV / Earnings	-3.08
EV / Sales	0.53
EV / EBITDA	6.45
EV / EBIT	9.10
EV / FCF	-25.73

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.31.

Current Ratio	1.47
Quick Ratio	1.06
Debt / Equity	0.31
Debt / EBITDA	2.80
Debt / FCF	-8.00
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is -27.46% and return on invested capital (ROIC) is 2.81%.

Return on Equity (ROE)	-27.46%
Return on Assets (ROA)	2.18%
Return on Invested Capital (ROIC)	2.81%
Return on Capital Employed (ROCE)	6.19%
Revenue Per Employee	1.30B
Profits Per Employee	-223.43M
Employee Count	202
Asset Turnover	1.00
Inventory Turnover	4.06

Taxes

Income Tax	-4.10B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.95% in the last 52 weeks. The beta is 0.28, so Theragen Etex's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-20.95%
50-Day Moving Average	2,996.30
200-Day Moving Average	3,075.98
Relative Strength Index (RSI)	36.89
Average Volume (20 Days)	50,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theragen Etex had revenue of KRW 263.43 billion and -45.13 billion in losses. Loss per share was -1,357.69.

Revenue	263.43B
Gross Profit	133.77B
Operating Income	9.19B
Pretax Income	-48.47B
Net Income	-45.13B
EBITDA	15.47B
EBIT	9.19B
Loss Per Share	-1,357.69

Balance Sheet

The company has 29.49 billion in cash and 43.29 billion in debt, giving a net cash position of -13.80 billion or -376.10 per share.

Cash & Cash Equivalents	29.49B
Total Debt	43.29B
Net Cash	-13.80B
Net Cash Per Share	-376.10
Equity (Book Value)	141.75B
Book Value Per Share	3,555.22
Working Capital	41.48B

Cash Flow

In the last 12 months, operating cash flow was 3.26 billion and capital expenditures -8.67 billion, giving a free cash flow of -5.41 billion.

Operating Cash Flow	3.26B
Capital Expenditures	-8.67B
Free Cash Flow	-5.41B
FCF Per Share	-147.49

Margins

Gross margin is 50.78%, with operating and profit margins of 3.49% and -17.13%.

Gross Margin	50.78%
Operating Margin	3.49%
Pretax Margin	-18.40%
Profit Margin	-17.13%
EBITDA Margin	5.87%
EBIT Margin	3.49%
FCF Margin	n/a

Dividends & Yields

Theragen Etex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.73%
Shareholder Yield	n/a
Earnings Yield	-42.43%
FCF Yield	-5.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theragen Etex has an Altman Z-Score of 2.05 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.05
Piotroski F-Score	6